Quantcast

Latest Tuberculosis treatment Stories

2005-12-22 14:19:20

NEW YORK (Reuters Health) - A small outbreak of tuberculosis (TB) infection in a newborn nursery and maternity ward in New York City two years ago appears to have been caused by a foreign-born worker in the ward who had been previously diagnosed with dormant or latent TB infection, but had refused treatment, according to a new report. The findings underscore the importance of effective testing for latent TB infection and treatment programs for healthcare workers "to prevent TB...

2005-11-08 08:22:36

By Katharine Houreld GBARNGA, Liberia (Reuters) - Like many young girls her age, 11-year-old Fatu Kerkular likes to dance, enjoys basketball and wants to be a nurse when she grows up. But above the chipped red nail polish on her toes, her legs are covered in white patches. On her face and neck, beneath star-shaped plastic earrings, her skin bears the same marks -- the telltale signs of the first stages of leprosy. Since she was discharged from her local hospital in May, the symptoms...

2005-10-03 15:08:55

FINDINGS: A UCLA/VA study found that for Hepatitis C patients who develop treatment-induced anemia due to a key medication, it is more cost-effective to take an additional drug to help prevent anemia, rather than reducing or stopping treatment altogether, which had been the standard approach. IMPACT: The study may lead to a new treatment standard for the one-third of Hepatitis C patients who develop treatment-induced anemia as a result of taking a key medication called ribarvirin. Over 4...

2005-06-15 18:31:49

In an area of high tuberculosis (TB) incidence, investigators found that the age-adjusted rate of disease reinfection after successful treatment for TB was four times that for new cases, according to a study in the American Thoracic Society\'s (ATS) peer-reviewed journal. The objective of the researchers\' study was to determine the incidence rate of TB attributable to reinfection among those successfully treated for the disease at an epidemiologic fieldsite in Cape Town, South Africa. The...

2005-06-14 17:44:35

A promising new drug candidate that may be effective against both actively dividing and slow-growing Mycobacterium tuberculosis (M. tb) has begun testing in humans, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, announced today. The novel antibiotic, PA-824, may shorten the time needed to treat tuberculosis (TB), a contagious disease that claims approximately two million lives worldwide each year. In partnership with the...

2005-06-07 18:40:03

International goals for reducing the number of tuberculosis cases and deaths to a certain number by the year 2015 can be achieved, but African and Eastern European countries could pose the greatest challenges, according to a study in the June 8 issue of JAMA, a theme issue on tuberculosis. Lead author Christopher Dye, D.Phil., from the World Health Organization, Geneva, Switzerland, presented the findings of the study at a JAMA media briefing on tuberculosis at the National Press Club. In...

2005-06-07 18:36:46

Risk factors for tuberculosis in the United States overlap with many of the risk factors associated with persistent homelessness, including being male or having a history of incarceration or substance abuse, according to a report in the June 8 issue of JAMA, a theme issue on tuberculosis. "Homelessness is associated with an increased risk of exposure to Mycobacterium tuberculosis, undetected and untreated infection, and subsequent progression to TB disease," according to background...

2004-11-27 03:00:10

Laboratorians have been on the front lines in the fight against tuberculosis (TB) ever since Dr. Robert Koch announced his discovery of the tuberculosis bacillus in 1882. The bacillus Mycobacterium tuberculosis (M tuberculosis) has a high concentration of lipids in the cell wall, which makes it the ultimate survivor. It is impermeable to stains and dyes, resistant to many antibiotics, resistant to killing by acidic and alkaline compounds, resistant to osmotic lysis via complement deposition,...

2004-11-25 03:00:15

Multidrug-resistant tuberculosis (MDR TB) caused by Mycobacterium tuberculosis resistant to both isoniazid and rifampicin with or without resistance to other drugs is among the most worrisome elements of the pandemic of antibiotic resistance. Globally, about three per cent of all newly diagnosed patients have MDR-TB. The proportion is higher in patients who have previously received antituberculosis treatment reflecting the failure of programmes designed to ensure complete cure of patients...


Word of the Day
reremouse
  • A bat.
The word 'reremouse' comes from Middle English reremous, from Old English hrēremūs, hrērmūs ("bat"), equivalent to rear (“to move, shake, stir”) +‎ mouse.
Related